☆ 4.2 Article

Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation

TRANSPLANTATION AND CELLULAR THERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India

Gaurav Kharya et al.

Summary: Allogenic hematopoietic cell transplantation (HCT) is the best curative approach for severe aplastic anemia (SAA), and HCT from haploidentical family donors (HFDs) has become a feasible option for patients lacking an HLA-identical donor. However, there is limited data on HFD-HCT for young SAA patients. A multicenter retrospective study evaluated the outcomes of 79 SAA patients undergoing HFD-HCT and found that PTCy-based HFD-HCT is a reasonable option for young patients with high-risk SAA, and optimization of conditioning and GVHD prophylaxis may further improve outcomes. The use of abatacept was found to have a favorable impact on GVHD and event-free survival (EFS).

TRANSPLANTATION AND CELLULAR THERAPY (2023)

添加到收藏夹

Letter Biophysics

Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia

Lan-Ping Xu et al.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Article Hematology

Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study

Zheng-Li Xu et al.

Summary: Allogeneic hematopoietic stem cell transplantation is an effective method for treating severe aplastic anemia, and haploidentical donor transplantation has made significant progress in this field. Based on a national registry analysis, the long-term outcomes of upfront haploidentical or identical sibling donor stem cell transplantation were compared, and it was found that both approaches led to similar overall survival and failure-free survival rates. Quality of life improved significantly after transplantation, and the occurrence of chronic graft-versus-host disease was identified as the only adverse factor affecting quality of life. The physical and mental well-being of patients were similar between the two transplantation methods.

HAEMATOLOGICA (2022)

添加到收藏夹

Article Hematology

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial

Amy E. DeZern et al.

Summary: Haploidentical bone marrow transplantation is effective in treating relapsed or refractory severe aplastic anaemia patients with high overall survival rates at 1 year, which can broaden access to bone marrow transplantation and be considered as a standard salvage treatment for severe aplastic anaemia in clinical practice. High cell doses from bone marrow harvests are crucial for the success of this approach.

LANCET HAEMATOLOGY (2022)

添加到收藏夹

Review Biophysics

The effect of hematopoietic stem cell transplantation on fertility and strategies for improvement

Brittany File et al.

Summary: This article reviews the impact of hematopoietic stem cell transplantation on ovarian function, post-transplant fertility and birth outcomes, as well as the strategies to preserve fertility for these patients.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Article Hematology

High Failure-Free Survival after Unrelated Donor Peripheral Blood Stem Cell Transplantation in Pediatric Severe Aplastic Anemia

Jae Won Yoo et al.

Summary: The study found that unrelated donor PBSCT with low-intensity conditioning for SAA showed favorable outcomes, including a low rate of secondary graft failure, higher FFS, and manageable GVHD, regardless of HLA compatibility.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

添加到收藏夹

Review Biophysics

Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges

Zheng-Li Xu et al.

Summary: HSCT is a curative option for SAA, with haploidentical donors providing expanded choices. Recent advancements in haplo-HSCT have overcome previous challenges and achieved inspiring survival outcomes in SAA. Different regimens such as G-CSF and ATG, PT-Cy, and TCD have been successful in promoting haplo-HSCT as a priority option for SAA patients without matched donors in China.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Review Oncology

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Xiao-hui Zhang et al.

Summary: The recent updated consensus recommendations from The Chinese Society of Hematology on allogeneic hematopoietic stem cell transplantation (allo-HSCT) include a new donor selection algorithm, encouraging salvage treatment with novel immunotherapies, and reflecting additional evidence for specific patient groups in transplantation application.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Biology

Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding

Keiko Akahane et al.

Summary: TBI with ovarian shielding reduces ovarian radiation dose to 2.4 Gy, preserving fertility without increasing relapse risk among hematopoietic stem cell transplant patients.

JOURNAL OF RADIATION RESEARCH (2021)

添加到收藏夹

Article Hematology

Haploidentical Peripheral Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide and Methotrexate

Kaitai Yang et al.

Summary: The study investigated a novel approach to HSCT, haploidentical peripheral blood stem cell transplantation, for patients with SAA who lack HLA-identical siblings or matched unrelated donors. The results showed promising outcomes with low rates of graft-versus-host disease, indicating the potential for safely expanding the donor pool for young patients with severe aplastic anemia.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

添加到收藏夹

Article Hematology

Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience

Yun Li et al.

Summary: Haploidentical transplantation with modified post-transplantation cyclophosphamide (PTCY) has shown promising results for aplastic anemia patients, leading to prolonged survival and reduced complications. The conditioning regimen consisting of various medications was effective in preventing graft versus host disease (GVHD) post-transplantation. Overall, the study demonstrated high rates of successful engraftment and survival among patients undergoing this treatment strategy.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

添加到收藏夹

Article Biophysics

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

Pedro H. Prata et al.

BONE MARROW TRANSPLANTATION (2020)

添加到收藏夹

Article Biophysics

Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases

Limin Liu et al.

BONE MARROW TRANSPLANTATION (2020)

添加到收藏夹

Article Hematology

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Amy E. DeZern et al.

BLOOD ADVANCES (2020)

添加到收藏夹

Article Hematology

Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia

Leonardo Javier Arcuri et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

添加到收藏夹

Article Hematology

Comparable Outcomes of First-Line Hematopoietic Stem Cell Transplantation from Unrelated and Matched Sibling Donors in Adult Patients with Aplastic Anemia: A Retrospective Single-Center Study

Yuping Zhang et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

添加到收藏夹

Article Virology

Serologic and viral genome prevalence of HSV, EBV, and HCMV among healthy adults in Wuhan, China

Le Wen et al.

JOURNAL OF MEDICAL VIROLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Aplastic Anemia

Neal S. Young

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Hematology

Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia

Liangliang Wu et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

添加到收藏夹

Article Oncology

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

Asad Bashey et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

Lan-Ping Xu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

F. M. Marty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Hematology

Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

Amy E. DeZern et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)

添加到收藏夹

Article Hematology

Guidelines for the diagnosis and management of adult aplastic anaemia

Sally B. Killick et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

添加到收藏夹

Article Hematology

Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study

Lan-Ping Xu et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

添加到收藏夹

Article Hematology

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party

Raynier Devillier et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article Hematology

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party

Raynier Devillier et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article Hematology

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies

Amin M. Alousi et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)

添加到收藏夹

Article Biophysics

Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study

I. Esteves et al.

BONE MARROW TRANSPLANTATION (2015)

添加到收藏夹

Article Hematology

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Andrea Bacigalupo et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Hematology

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Andrea Bacigalupo et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Hematology

Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation

Yoshinobu Kanda et al.

ANNALS OF HEMATOLOGY (2014)

添加到收藏夹

Article Biophysics

Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab

W. J. F. M. van der Velden et al.

BONE MARROW TRANSPLANTATION (2013)

添加到收藏夹

Article Hematology

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

Andrea Bacigalupo et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)

添加到收藏夹

Article Hematology

Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies

Mehdi Hamadani et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

添加到收藏夹

Article Hematology

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Ola Landgren et al.

BLOOD (2009)

添加到收藏夹

Article Hematology

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

Leo Luznik et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)

添加到收藏夹

Review Hematology

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

AH Filipovich et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)

添加到收藏夹

Article Biophysics

Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection

FL Dulley et al.

BONE MARROW TRANSPLANTATION (2004)

添加到收藏夹

Article Immunology

Definitions of cytomegalovirus infection and disease in transplant recipients

P Ljungman et al.

CLINICAL INFECTIOUS DISEASES (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.